Prelude Therapeutics (PRLD) Institutional Ownership $0.74 +0.06 (+8.19%) Closing price 04:00 PM EasternExtended Trading$0.78 +0.04 (+4.73%) As of 04:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Prelude Therapeutics (NASDAQ:PRLD)CurrentInstitutional OwnershipPercentage79.72%Number ofInstitutional Buyers(last 12 months)22TotalInstitutional Inflows(last 12 months)$6.00MNumber ofInstitutional Sellers(last 12 months)8TotalInstitutional Outflows(last 12 months)$936.22K Get PRLD Insider Trade Alerts Want to know when executives and insiders are buying or selling Prelude Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PRLD Institutional Buying and Selling by Quarter Prelude Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Two Sigma Investments LP231,839$296K0.0%+307.2%0.421% 2/17/2025 Two Sigma Advisers LP300,000$382K0.0%+526.3%0.545% 2/17/2025 Millennium Management LLC462,555$590K0.0%+188.2%0.841% 2/17/2025 Jacobs Levy Equity Management Inc.666,574$850K0.0%+280.9%1.211% 2/17/2025 Deutsche Bank AG123,899$159K0.0%+747.6%0.225% 2/17/2025 Bridgeway Capital Management LLC111,000$142K0.0%-37.0%0.202% 2/17/2025 BNP Paribas Financial Markets20,572$26K0.0%N/A0.037% 2/14/2025 Boxer Capital Management LLC1,708,187$2.18M0.2%N/A3.104% 2/14/2025 Northern Trust Corp83,387$106K0.0%-21.6%0.152% 2/14/2025 Price T Rowe Associates Inc. MD1,029,199$1.31M0.0%-6.2%1.870% Get the Latest News and Ratings for PRLD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Prelude Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025 Marshall Wace LLP392,155$498K0.0%+9.2%0.713% 2/13/2025 Renaissance Technologies LLC634,500$809K0.0%+222.2%1.153% 2/12/2025 Massachusetts Financial Services Co. MA494,497$630K0.0%-10.0%0.899% 2/12/2025 JPMorgan Chase & Co.61,149$78K0.0%+925.0%0.111% 2/6/2025 Charles Schwab Investment Management Inc.117,200$149K0.0%-12.0%0.213% 1/30/2025 Rhumbline Advisers166,830$213K0.0%+1,289.8%0.303% 11/19/2024 Barclays PLC27,165$57K0.0%+86.0%0.049% 11/16/2024 Geode Capital Management LLC391,716$811K0.0%+8.2%0.712% 11/15/2024 Barclays PLC27,165$57K0.0%+86.0%0.049% 11/15/2024 XTX Topco Ltd48,239$100K0.0%N/A0.088% 11/15/2024 State Street Corp286,046$592K0.0%+35.1%0.520% 11/15/2024 Jacobs Levy Equity Management Inc.174,979$362K0.0%+885.2%0.318% 11/14/2024 Walleye Capital LLC83,175$172K0.0%+446.2%0.151% 11/12/2024 Massachusetts Financial Services Co. MA549,530$1.14M0.0%+5.2%0.999% 10/10/2024 Exchange Traded Concepts LLC64,409$133K0.0%+32.2%0.153% 8/15/2024 The Manufacturers Life Insurance Company70,045$267K0.0%-3.1%0.166% 8/9/2024 Renaissance Technologies LLC206,600$787K0.0%-15.6%0.491% 8/9/2024 Dimensional Fund Advisors LP29,074$111K0.0%+103.2%0.069% 8/9/2024 Massachusetts Financial Services Co. MA522,375$1.99M0.0%+2.8%1.241% 7/26/2024 Bank of New York Mellon Corp36,276$138K0.0%-9.5%0.086% 5/16/2024 Kennedy Capital Management LLC25,035$119K0.0%N/A0.059% 5/15/2024 Price T Rowe Associates Inc. MD941,971$4.47M0.0%-9.7%2.239% 5/10/2024 Acadian Asset Management LLC22,110$104K0.0%+42.7%0.053% 5/10/2024 Vanguard Group Inc.1,016,999$4.82M0.0%+1.0%2.417% 2/15/2024 Boxer Capital LLC2,568,287$10.97M0.5%+2.9%4.684% 2/14/2024 Pale Fire Capital SE63,581$271K0.0%+106.6%0.116% 1/12/2024 SG Americas Securities LLC13,100$56K0.0%N/A0.024% 1/5/2024 Exchange Traded Concepts LLC44,087$188K0.0%+34.0%0.080% 11/14/2023 Pale Fire Capital SE30,781$95K0.0%N/A0.056% 11/13/2023 FMR LLC5,131,433$15.86M0.0%-13.6%9.359% Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret.11/7/2023 Barclays PLC13,316$42K0.0%+120.0%0.024% 10/27/2023 TD Asset Management Inc160,652$496K0.0%+100.0%0.293% 10/18/2023 Exchange Traded Concepts LLC32,907$102K0.0%+29.4%0.060% 9/21/2023 Barclays PLC6,052$27K0.0%-41.4%0.011% 8/15/2023 Boxer Capital LLC2,495,018$11.23M0.5%+256.9%4.552% 8/9/2023 TD Asset Management Inc80,326$361K0.0%+182.4%0.147% 7/20/2023 Exchange Traded Concepts LLC25,428$114K0.0%N/A0.053% 5/16/2023 Boxer Capital LLC699,047$3.99M0.2%N/A1.458% 5/1/2023 Virtu Financial LLC11,201$64K0.0%N/A0.023% 2/14/2023 683 Capital Management LLC28,631$173K0.0%N/A0.060% 2/13/2023 GSA Capital Partners LLP47,801$289K0.0%-11.8%0.100% 2/10/2023 New York Life Investment Management LLC82,000$495K0.0%+11.7%0.171% 2/9/2023 Citigroup Inc.60,072$363K0.0%+604.1%0.126% 2/7/2023 Bleakley Financial Group LLC22,325$135K0.0%N/A0.047% 11/15/2022 Caxton Associates LP85,992$568K0.1%+2.5%0.180% 11/14/2022 PDT Partners LLC12,641$84K0.0%-71.1%0.026% 11/9/2022 Massachusetts Financial Services Co. MA513,293$3.39M0.0%+7.3%1.073% 10/25/2022 Denali Advisors LLC8,200$54K0.0%N/A0.017% 8/16/2022 Corton Capital Inc.15,586$81K0.1%+42.8%0.033% 8/16/2022Delphia USA Inc.16,940$88K0.1%N/A0.035% 8/13/2022 Massachusetts Financial Services Co. MA478,525$2.50M0.0%-0.7%1.000% 8/12/2022 Virtus ETF Advisers LLC24,005$125K0.0%+84.0%0.050% 7/19/2022 Commonwealth Equity Services LLC16,617$86K0.0%-18.8%0.035% 5/11/2022 Massachusetts Financial Services Co. MA482,119$3.33M0.0%+2.8%1.012% 5/11/2022 GSA Capital Partners LLP23,201$160K0.0%N/A0.049% 5/6/2022IndexIQ Advisors LLC56,750$392K0.0%N/A0.119% 5/5/2022 New York State Common Retirement Fund4,992$34K0.0%-45.1%0.010% 5/4/2022 Commonwealth Equity Services LLC20,467$141K0.0%-10.4%0.043% 3/3/2022 Walleye Capital LLC41,954$522K0.0%N/A0.089% 2/14/2022 PDT Partners LLC35,907$447K0.0%N/A0.076% 2/14/2022 Virtus ETF Advisers LLC13,815$172K0.1%+119.6%0.029% 2/14/2022 Point72 Hong Kong Ltd3,872$48K0.0%+141.7%0.008% 2/11/2022 Ensign Peak Advisors Inc8,080$101K0.0%N/A0.017% 2/11/2022 Parkwood LLC12,667$158K0.0%N/A0.027% 2/10/2022 Qube Research & Technologies Ltd23,384$291K0.0%N/A0.050% 2/10/2022 Massachusetts Financial Services Co. MA468,797$5.84M0.0%-0.7%0.993% 2/8/2022 Swiss National Bank27,500$342K0.0%+34.1%0.058% 2/1/2022 Qube Research & Technologies Ltd23,384$291K0.0%N/A0.050% 1/31/2022 Commonwealth Equity Services LLC22,832$284K0.0%+69.4%0.048% 12/14/2021 UBS Asset Management Americas Inc.1,483,319$46.35M0.0%+15.2%3.142% 11/15/2021 Point72 Hong Kong Ltd1,602$50K0.0%N/A0.003% 11/15/2021 Cubist Systematic Strategies LLC21,755$680K0.0%+26.5%0.046% 11/15/2021 California State Teachers Retirement System13,524$423K0.0%-9.5%0.029% 11/15/2021 Rock Springs Capital Management LP362,359$11.32M0.2%-5.2%0.769% 11/15/2021 Morgan Stanley756,787$23.65M0.0%+472.6%1.607% 11/12/2021Credit Suisse AG6,950$216K0.0%N/A0.015% 11/12/2021 Geode Capital Management LLC249,172$7.79M0.0%+11.6%0.529% 11/10/2021 Goldman Sachs Group Inc.8,659$271K0.0%-53.5%0.018% 11/10/2021 Citigroup Inc.24,268$758K0.0%-67.9%0.052% 11/10/2021 Rafferty Asset Management LLC36,936$1.15M0.0%-25.8%0.078% Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret.11/10/2021 Alliancebernstein L.P.13,700$428K0.0%-23.5%0.029% 11/10/2021 Massachusetts Financial Services Co. MA472,246$14.76M0.0%+25.9%1.003% 11/9/2021BlackRock Inc.725,962$22.69M0.0%+3.3%1.542% 11/4/2021 Deutsche Bank AG6,537$205K0.0%-82.4%0.014% 11/1/2021 SG Americas Securities LLC8,691$272K0.0%N/A0.018% 10/29/2021 Commonwealth Equity Services LLC13,482$421K0.0%+23.4%0.029% 8/17/2021 Logos Global Management LP400,000$11.45M1.0%N/A0.852% 8/17/2021 Metropolitan Life Insurance Co NY3,194$91K0.0%+106,366.7%0.007% 8/17/2021 Price T Rowe Associates Inc. MD400,802$11.48M0.0%-5.2%0.854% 8/16/2021 UBS Asset Management Americas Inc.1,287,735$36.87M0.0%+100.3%2.742% (Data available from 1/1/2016 forward) PRLD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PRLD shares? During the previous two years, 34 institutional investors and hedge funds held shares of Prelude Therapeutics. The most heavily invested institutionals were FMR LLC ($15.86M), Boxer Capital LLC ($10.97M), Vanguard Group Inc. ($4.82M), Boxer Capital Management LLC ($2.18M), Price T Rowe Associates Inc. MD ($1.31M), Jacobs Levy Equity Management Inc. ($850K), and Geode Capital Management LLC ($811K).Learn more on PRLD's institutional investors. What percentage of Prelude Therapeutics stock is owned by institutional investors? 79.72% of Prelude Therapeutics stock is owned by institutional investors. Learn more on PRLD's institutional investor holdings. Which institutional investors have been buying Prelude Therapeutics stock? Of the 27 institutional investors that purchased Prelude Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Boxer Capital LLC ($2.57M), Boxer Capital Management LLC ($1.71M), Jacobs Levy Equity Management Inc. ($648.81K), Renaissance Technologies LLC ($437.60K), Millennium Management LLC ($302.03K), Two Sigma Advisers LP ($252.10K), and Two Sigma Investments LP ($174.91K). How much institutional buying is happening at Prelude Therapeutics? Institutional investors have bought a total of 7,095,252 shares in the last 24 months. This purchase volume represents approximately $19.42M in transactions. Which Prelude Therapeutics major shareholders have been selling company stock? Of the 10 institutional investors that sold Prelude Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: FMR LLC ($808.79K), Price T Rowe Associates Inc. MD ($169.17K), Bridgeway Capital Management LLC ($65.10K), Massachusetts Financial Services Co. MA ($55.03K), Renaissance Technologies LLC ($38.20K), Northern Trust Corp ($22.99K), and Charles Schwab Investment Management Inc. ($16.05K). How much institutional selling is happening at Prelude Therapeutics? Institutional investors have sold a total of 1,185,604 shares in the last 24 months. This volume of shares sold represents approximately $3.45M in transactions. Related Companies Genfit Major Shareholders Pliant Therapeutics Major Shareholders Compugen Major Shareholders CARGO Therapeutics Major Shareholders Ocugen Major Shareholders Inhibikase Therapeutics Major Shareholders Enanta Pharmaceuticals Major Shareholders Inhibrx Major Shareholders INmune Bio Major Shareholders Nanobiotix Major Shareholders This page (NASDAQ:PRLD) was last updated on 3/4/2025 by MarketBeat.com Staff From Our Partners77 Hedge Funds Are Betting On This Off-Radar MineralWith surging prices... supply shortages... and growing demand, hedge funds are betting big on potash. In fa...The Tomorrow Investor | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prelude Therapeutics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Prelude Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRLD Stock Alerts